TNF and Decreased liver function: Hypotension, leukopenia, thrombocytopenia, fever, headache, nausea and hepatopathy represent the most common side effects detected in Phase II studies with recombinant TNF, while most serious toxicities include respiratory failure and coagulopathies [40].